Related Products
Retatrutide 20mg
20mg
Retatrutide 10mg
10mg
GHK-Cu 50mg
50mg
GLOW 70mg
70mg
Related Research News
Ozempic and Wegovy linked to drop in violent behavior, study finds
A new study has found that the popular GLP-1 drugs Ozempic and Wegovy are linked to a decrease in violent behavior among users. The research, reported by NewsNation, adds to the growing body of evidence suggesting these medications may have broader effects beyond weight loss and blood sugar control.
Semaglutide News: Ozempic Linked to Fewer Bone Fractures Despite Greater Weight Loss
New data presented at the American Diabetes Association annual meeting suggests semaglutide (Ozempic, Wegovy) may reduce bone fracture risk, even with significant weight loss. The findings add a new layer to the safety profile of GLP-1 receptor agonists and have implications for peptide research.
GLP-1 Drugs Linked to Reduced Crime-Related Behavior
A report from Inside Precision Medicine indicates that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may be associated with a reduction in crime-linked behaviors. The findings suggest potential broader societal impacts of these medications beyond metabolic health.